Funder
McGill University’s Department of Epidemiology, Biostatistics, and Occupational Health
Bill & Melinda Gates Foundation
World Health Organization Initiative for Vaccine Research
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference29 articles.
1. World Health Organization. Preferred Product Characteristics for Respiratory Syncytial Virus (RSV) Vaccines. Geneva, Switzerland: World Health Organization; 2017.
2. Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics;Vekemans;Vaccine,2018
3. Efficacy of maternal influenza vaccination against all-cause lower respiratory tract infection hospitalizations in young infants: results from a randomized controlled trial;Nunes;Clin Infect Dis,2017
4. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study;Shi;Lancet (London, England),2017
5. Risk of primary infection and reinfection with respiratory syncytial virus;Glezen;Am J Dis Child,1986
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献